 |
Cellebrite Guardian Simplifies and Secures Digital Evidence Management, Sharing, & Review as Part of a Public Safety Agency's Investigative Workflow
PETAH TIKVA, Israel, Oct. 26, 2021 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, today announced the release of a new version of Cellebrite Guardian, now the industry's most comprehensive cloud-based investigative digital evidence management system (DEMS) designed to transform evidence and workflow management throughout the entire investigative process. Guardian is the latest offering in Cellebrite's end-to-end Investigative Digital Intelligence (DI) Platform, trusted by agencies across the globe to transform their investigations to become smarter, faster, and more efficient.
Guardian provides unique and innovative capabilities that will help agencies address their "big data" investigative challenges and siloed working groups. This is done through linking multiple parts of the investigative workflow: evidence management, storage, sharing, reporting and unmatched review capabilities – together in one simple, secure, and scalable system, to get to the relevant facts of the case more quickly.
"Digital evidence management is top of mind for public safety agencies globally as they continue to put a focus on implementing strategies to manage digital evidence and protect privacy as part of investigations," said Alison Brooks, Vice President for IDC's Worldwide and US Public Safety practices. "Agencies are continuing to rely more and more on finding the relevant digital evidence in massive data volumes to keep the public safe. Because of this we are seeing an increasing use of investigative digital evidence management solutions, as well as cloud compute platforms in public safety to transform investigations with agility, scalability and speed."
Accelerating Case Time-To-Resolution
A cloud-based investigative DEMS provides agencies with a more efficient and cost-effective alternative than manual processes or an on-premise system by eliminating risk and driving down the cost of storage, hardware and system maintenance spend. By leveraging the highly secure AWS GovCloud environment, Guardian also provides additional security benefits. Leveraging the benefits of running on the AWS Cloud, Guardian accelerates an agency's case time-to-resolution and streamlines collaboration between the different stakeholders in the digital investigative process.
Eliminating Manual Processes
In many agencies, digital evidence management is still a manual, cumbersome process involving USB drives, DVDs or CD-ROMs and inadequate hardware devices to review and share large files quickly.
Cellebrite Guardian eliminates manual processes by moving the digital evidence management process into a Cloud environment. This approach:
"Today, agencies are looking for any edge they can get from the start of an investigation." said Ronnen Armon, Cellebrite's Chief Product and Technology Officer. "At Cellebrite, our focus is on helping agencies transform their investigations to become smarter, faster, and more efficient. This version of Cellebrite Guardian provides a comprehensive, cost-effective solution to help them store, share and review digital and physical evidence, which is one of the biggest challenges they face today."
General availability for this version of Cellebrite Guardian is expected in Q4 of 2021. For more information, please visit here.
About Cellebrite
Cellebrite's (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies world-wide, Cellebrite's Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com and https://investors.cellebrite.com.
Caution Regarding Forward Looking Statements
This document includes "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward looking statements include estimated financial information. Such forward looking statements with respect to revenues, earnings, performance, strategies, prospects and other aspects of the business of Cellebrite are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward looking statements. These factors include, but are not limited to: Cellebrite's ability to develop technologically advanced solutions and successfully integrate with the software solutions used by customers; acceptance of solutions by customers; errors, failures, defects or bugs in solutions; a failure to maintain sales and marketing personnel productivity or hire, integrate and retain additional sales and marketing personnel; the impact of the global COVID-19 pandemic; the impact of competition on pricing and on Cellebrite's market share; sub-optimal results from products due to misuse by customers; Cellebrite's failure to maintain and enhance its reputation and brand; inaccuracy of the estimates of Cellebrite's market opportunity and forecasts of market growth; changes to packaging and licensing models that adversely affect the ability to attract or retain customers; failure to manage future growth effectively; failure to introduce new solutions and add-ons; issues in the use of artificial intelligence resulting in reputational harm or liability; the need for additional capital to support the growth of Cellebrite's business; a failure to maintain the security of operations and the integrity of software solutions; the impact of government budgeting cycles and appropriations, early termination, audits, investigations, sanctions and penalties; a decline in government budgets, changes in spending or budgetary priorities, or delays in contract awards; a failure to adequately obtain, maintain, protect and enforce Cellebrite's intellectual property or infringement of the intellectual property rights of others; perceptions or court or regulatory decisions that Cellebrite's solutions violate privacy rights; the use of solutions by customers in a way that is, or that is perceived to be, incompatible with human rights; failure to comply with laws regarding privacy, data protection and security, technology protection, sanctions, export controls and other matters; and other factors, risks and uncertainties set forth in the sections titled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the final proxy statement/prospectus relating to Cellebrite's consummated business combination filed with the SEC on August 5, 2021 and in other documents filed by Cellebrite with the SEC, which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media
Adam Jaffe
VP of Global Communications
+1 973 206 7643
adam.jaffe@cellebrite.com – or –
RapidResponse@cellebrite.com
Investors
Anat Earon-Heilborn
VP Investor Relations
+972 73 394 8440
investors@cellebrite.com
Logo - https://mma.prnasia.com/media2/1193846/Cellebrite_Logo.jpg?p=medium600
